Propanc Biopharma, Inc. (PPCB)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -935.11 Thousand | -1.1 Million | -1.43 Million | -1.14 Million | -1.84 Million | -2.06 Million |
| Net Income | -1.82 Million | -2.66 Million | -2.65 Million | -2.02 Million | -4.74 Million | -5.75 Million |
| Depreciation & Amortization | 21.65 Thousand | 22.93 Thousand | 5671.00 | 1993.00 | 2473.00 | 2306.00 |
| Deferred income taxes | - | -141.36 | -387.14 | 78.17 Thousand | 528.11 Thousand | -245.14 |
| Stock-based compensation | - | 141.35 Thousand | 387.13 Thousand | 82.87 Thousand | 300.41 Thousand | 245.14 Thousand |
| Change in working capital | 417.41 Thousand | 472.58 Thousand | 167.43 Thousand | 439.04 Thousand | 212.54 Thousand | 502.63 Thousand |
| Other non-cash items | 297.83 Thousand | 1.05 Million | 1.04 Million | 278.59 Thousand | 1.84 Million | 3.19 Million |
| Investing Cash Flow | - | - | - | - | - | -2874.00 |
| Investments in PPE | -2.00 | - | - | - | - | -2874.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -2874.00 |
| Financing Cash Flow | 941.89 Thousand | 1.11 Million | 1.49 Million | 1.05 Million | 1.89 Million | 2.11 Million |
| Debt repayment | -918.83 Thousand | -590.25 Thousand | -766.5 Thousand | -43 Thousand | -1.46 Million | -272 Thousand |
| Dividends payments | -192.96 Thousand | -466.27 Thousand | -700.34 Thousand | -391.74 Thousand | - | - |
| Common Stock Repurchased | - | - | -766.5 Thousand | -776.04 Thousand | - | - |
| Common Stock Issuance | 23.05 Thousand | 499.71 Thousand | 99.28 Thousand | 776.04 Thousand | 450 Thousand | 1.1 Million |
| Other Financing Activities | 1.11 Million | 1.11 Million | 3.62 Million | 1.49 Million | 2.9 Million | 1.29 Million |
| Accounts receivables | -71.00 | -610.00 | 1660.00 | -2147.00 | 3332.00 | 489.00 |
| Accounts payables | 242.4 Thousand | 80.97 Thousand | 18.87 Thousand | 178.31 Thousand | -59.73 Thousand | -164.92 Thousand |
| Inventory | - | 610.00 | -1660.00 | 2147.00 | -3332.00 | -489.00 |
| Other working capital | 24.19 Thousand | 391.61 Thousand | 148.56 Thousand | 260.73 Thousand | 272.28 Thousand | 667.56 Thousand |
| Cash at beginning of period | 10.04 Thousand | 4067.00 | 2255.00 | 67 Thousand | 2394.00 | 19.92 Thousand |
| Cash at end of period | 21.08 Thousand | 10.04 Thousand | 4067.00 | 2255.00 | 67 Thousand | 2394.00 |
| Capital Expenditure | -2.00 | - | - | - | - | -2874.00 |
| Effect of forex changes on cash | 4262.00 | -2488.00 | -52.67 Thousand | 22.46 Thousand | 23.96 Thousand | -73.17 Thousand |
| Net cash flow / Change in cash | 11.03 Thousand | 5980.00 | 1812.00 | -64.75 Thousand | 64.61 Thousand | -17.52 Thousand |
| Free Cash Flow | -935.12 Thousand | -1.1 Million | -1.43 Million | -1.14 Million | -1.84 Million | -2.06 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -358.57 Thousand | -526.7 Thousand | -584.38 Thousand | -350.86 Thousand | -2.66 Million | -748.04 Thousand |
| Depreciation & Amortization | 5764.00 | 4773.00 | 5857.00 | 5262.00 | 22.93 Thousand | 5557.00 |
| Deferred income taxes | - | - | - | - | -141.36 | 2408.00 |
| Stock-based compensation | - | - | - | - | 141.35 Thousand | 82.13 Thousand |
| Change in working capital | -104.18 Thousand | 338.67 Thousand | 87.77 Thousand | 96.97 Thousand | 472.58 Thousand | -7412.00 |
| Other non-cash items | 48.98 Thousand | 13.84 Thousand | 251.87 Thousand | -84.83 Thousand | 1.05 Million | 571.92 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 4.18 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 250.97 Thousand | 70.26 Thousand | 273.92 Thousand | 350.34 Thousand | 1.11 Million | 100 Thousand |
| Debt repayment | -238.99 Thousand | -561.16 Thousand | -272.33 Thousand | -142.9 Thousand | -590.25 Thousand | -9751.55 |
| Dividends payments | - | - | - | -142.57 Thousand | -466.27 Thousand | -331.51 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 11.97 Thousand | 11.1 Thousand | - | - | 499.71 Thousand | 92.69 Thousand |
| Other Financing Activities | -120.28 Thousand | 664.79 | 546.25 Thousand | 635.83 Thousand | 1.11 Million | 100 Thousand |
| Accounts receivables | 2396.44 | -1493.93 | -1105.90 | 132.00 | -610.00 | 469.40 |
| Accounts payables | -58.00 | 74.21 Thousand | 20.52 Thousand | 148.83 Thousand | 80.97 Thousand | 53.02 Thousand |
| Inventory | - | - | 1105.90 | -132.00 | 610.00 | -469.40 |
| Other working capital | -11.57 Thousand | 265.95 Thousand | 67.24 Thousand | -51.85 Thousand | 391.61 Thousand | -60.43 Thousand |
| Cash at beginning of period | 6222.00 | 71.65 Thousand | 6625.00 | 10.04 Thousand | 4067.00 | 93.24 Thousand |
| Cash at end of period | 21.08 Thousand | 6222.00 | 71.65 Thousand | 6625.00 | 10.04 Thousand | 10.04 Thousand |
| Capital Expenditure | 4.18 | - | - | - | - | - |
| Effect of forex changes on cash | 23.85 Thousand | -29.26 Thousand | 29.98 Thousand | -20.31 Thousand | -2488.00 | -5221.00 |
| Net cash flow / Change in cash | 14.86 Thousand | -65.42 Thousand | 65.02 Thousand | -3422.00 | 5980.00 | -83.19 Thousand |
| Free Cash Flow | -259.96 Thousand | -106.22 Thousand | -238.88 Thousand | -333.45 Thousand | -1.1 Million | -177.97 Thousand |
300259
TRUE
MOHCY
FLUG-B
ABBV
IFAM